Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2023
April 13, 2023 17:56 ET
|
Hofseth Biocare ASA
The Annual General Meeting of Hofseth BioCare ASA will be held at the company's premises at Kipervikgata 13, 6003 Ålesund, on 28 April 2023 at 13:00 CET. The notice of the Annual General Meeting...
Hofseth Biocare ASA: HBC ANNUAL REPORT 2022
March 31, 2023 02:00 ET
|
Hofseth Biocare ASA
The Board of Directors of Hofseth BioCare ASA (“HBC”) has approved the financial statements for 2022 and the Company has today published the Annual Report and Sustainability Report for 2022. Please...
Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION
February 28, 2023 02:00 ET
|
Hofseth Biocare ASA
Bomi Framroze Holding AS, a close associate of primary insider and Chief Scientific Officer Dr. Bomi Framroze in Hofseth Biocare ASA ("HBC"), has on 27 February 2023 purchased 200,000 shares in HBC at...
Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION
February 17, 2023 02:00 ET
|
Hofseth Biocare ASA
Christoph Baldegger, primary insider and member of the board of directors in Hofseth BioCare ASA ("HBC") has today purchased 100,000 shares in HBC at an average price of NOK 2.72 per share. As a...
Hofseth Biocare ASA:
February 15, 2023 12:12 ET
|
Hofseth Biocare ASA
Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12 ...
Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION
February 15, 2023 12:12 ET
|
Hofseth Biocare ASA
Hofseth International AS ("HI"), a close associate of Hofseth Biocare ASA's (the "Company") board member Roger Hofseth, has notified the Company that HI has made the following purchases of shares in...
Hofseth Biocare ASA: FOURTH QUARTER 2022 & FULL YEAR FINANCIAL REPORT
February 10, 2023 02:00 ET
|
Hofseth Biocare ASA
In Q4, the ingredients business continued to show favorable momentum with growth of 87 %, compared to same quarter last year on an underlying basis, generating sales revenues of NOK 34m, compared to...
Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE
December 30, 2022 04:08 ET
|
Hofseth Biocare ASA
Ødegård Prosjekt AS, a wholly owned company of Jon Olav Ødegård has today, 30 December 2022, bought 70,000 shares at an average price of NOK 2.91 per share. Jon Olav Ødegård is CEO and primary insider...
Hofseth Biocare ASA: THIRD QUARTER 2022 FINANCIAL REPORT
November 11, 2022 02:00 ET
|
Hofseth Biocare ASA
Highlights in the third quarter - HBC grew revenue by 105 % year-on-year shows strength of our business in uncertain times and during the third quarter, HBC signed contracts with new salmon...
Hofseth Biocare ASA: STANFORD SCHOOL OF MEDICINE SUCCESSFULLY COMPLETES PRE-CLINICAL TRIAL WORK TESTING PROGO® BIOACTIVE PEPTIDES IN EFFECTIVE GUT HEALTH SUPPORT
October 17, 2022 03:24 ET
|
Hofseth Biocare ASA
The study, published in prestigious peer-reviewed journal Biomolecules by MDPI, was conducted through a collaboration between Hofseth BioCare (HBC) and Stanford University School of Medicine. It aimed...